This section contains information intended for healthcare professionals. Please certify that you are a healthcare professional.

Please indicate your country of residence:

What language is your preference?

COVID-19 is a respiratory disease associated with endothelitis and microthrombosis, that’s why the Von Willebrand factor vWF emerges as a candidate for biomarker of COVID-19 prognosis.

The scientific literature continues to grow in the correlation of biomarkers with the prognosis of patients with

COVID-19, to give them personalized attention. The following study shows that of the endothelial biomarkers analyzed, vWF is the only one that correlates in magnitude with the severity of disease progression, being very useful in hospitals as a tool for predicting mortality.

Read the publication

Featured products

See all instruments See all tests

Learn more about our unique technologies

Indirect Immunofluorescence Assays (IFA)

The gold-standard screening technology.

Learn more

SMC Technology

Efficient, reliable and flexible for optimized patient care.

Learn more

Enzyme-Linked Immunosorbent Assay (ELISA)

Most standardized technology for antibody detection.

Learn more

Capillary Electrophoresis

The worldwide leader in Capillary Electrophoresis with fully automated protein separation at high resolution.

Learn more

Gel Electrophoresis

Comprehensive menu with high-quality results on Agarose gel.

Learn more

This section contains information intended for wide distribution and may therefore contain product details or information that is not available or valid in your country.

Please contact your local Sebia representative. Information intended for healthcare professionals.
Carefully read the instructions in the reagent package inserts and instrument manuals.